Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Frontiers in Oncology
|
February 17, 2023
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
Serena Di Cosimo, Chiara M Ciniselli, Sara Pizzamiglio, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 2, 2025
ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs
Giovanna Talarico, Mara Lecchi, Anna Zanichelli, et al.
Clinical Breast Cancer
|
August 29, 2024
Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast
Chiara M Ciniselli, Paolo Verderio, Paolo Baili, et al.
Frontiers in Molecular Biosciences
|
October 13, 2022
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world
Serena Di Cosimo, Eliana La Rocca, Silva Ljevar, et al.
European Urology Oncology
|
September 23, 2019
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study
Giuseppe Procopio, Giulia Apollonio, Francesco Cognetti, et al.
Therapeutic Advances in Medical Oncology
|
January 24, 2024
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)
Pierangela Sepe, Giuseppe Procopio, Chiara Carlotta Pircher, et al.
Science Translational Medicine
|
March 11, 2026
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value
Carolina Reduzzi, Eleonora Nicolò, Lorenzo Gerratana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis
Sara Pizzamiglio, Chiara Maura Ciniselli, Tiziana Triulzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2016
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer
Matthew P Humphries, Sreekumar Sundara Rajan, Alastair Droop, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Frontiers in Oncology
|
February 17, 2023
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
Serena Di Cosimo, Chiara M Ciniselli, Sara Pizzamiglio, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 2, 2025
ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs
Giovanna Talarico, Mara Lecchi, Anna Zanichelli, et al.
Clinical Breast Cancer
|
August 29, 2024
Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast
Chiara M Ciniselli, Paolo Verderio, Paolo Baili, et al.
Frontiers in Molecular Biosciences
|
October 13, 2022
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world
Serena Di Cosimo, Eliana La Rocca, Silva Ljevar, et al.
European Urology Oncology
|
September 23, 2019
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study
Giuseppe Procopio, Giulia Apollonio, Francesco Cognetti, et al.
Therapeutic Advances in Medical Oncology
|
January 24, 2024
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)
Pierangela Sepe, Giuseppe Procopio, Chiara Carlotta Pircher, et al.
Science Translational Medicine
|
March 11, 2026
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value
Carolina Reduzzi, Eleonora Nicolò, Lorenzo Gerratana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis
Sara Pizzamiglio, Chiara Maura Ciniselli, Tiziana Triulzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2016
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer
Matthew P Humphries, Sreekumar Sundara Rajan, Alastair Droop, et al.
Page
of 7